Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis
Ji‐Seung Yoo, Michihito Sasaki, Steven X. Cho, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 145

Showing 26-50 of 145 citing articles:

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Murad Alahdal, Eyad Elkord
Clinical Immunology (2022) Vol. 245, pp. 109177-109177
Open Access | Times Cited: 29
IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation
Srikanth Sadhu, Rajdeep Dalal, Jyotsna Dandotiya, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 6
Open Access | Times Cited: 8
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 743
Open Access | Times Cited: 8
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to downregulate MHC-I surface expression
Najla Arshad, Maudry Laurent-Rolle, Wesam S. Ahmed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 24
Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
Hoda Zarkoob, Anna Allué‐Guardia, Yu‐Chi Chen, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Distinct mechanisms of dysfunctional antigen‐presenting DCs and monocytes by single‐cell sequencing in multiple myeloma
Jinxing Jiang, Jing Xiang, Mengping Chen, et al.
Cancer Science (2023) Vol. 114, Iss. 7, pp. 2750-2760
Open Access | Times Cited: 14
HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
Hongbing Yang, Hong Sun, Simon Brackenridge, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 14
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
Marjahan Akhtar, Md. Rashedul Islam, Fatema Khaton, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Multiplexed fluorescence and scatter detection with single cell resolution using on-chip fiber optics for droplet microfluidic applications
Preksha Gupta, Ambili Mohan, Apurv Mishra, et al.
Microsystems & Nanoengineering (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2
Brian C. Ware, M. Guston Parks, Mariana Oliveira Lopes da Silva, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1011794-e1011794
Open Access | Times Cited: 6
SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2
Nima Taefehshokr, Alex Lac, Angela M. Vrieze, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 10
Open Access | Times Cited: 5
SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expression
M. Z. Hasan, Maren Claus, Nadine Krüger, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants
Shasha Deng, Zhihao Xu, Meihua Wang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107563-107563
Open Access | Times Cited: 5
Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell anti-tumor immunity
Qian Yu, Dong Yu, Xiaobo Wang, et al.
JCI Insight (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 5
Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2
Ranjan Ramasamy
Viruses (2022) Vol. 14, Iss. 5, pp. 933-933
Open Access | Times Cited: 22
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins
Fengwen Zhang, Trinity Zang, Eva M. Stevenson, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 41
Open Access | Times Cited: 22
XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity
Han Yu, Xue Bai, Siying Liu, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 21
NLRC5 restricts dengue virus infection by promoting the autophagic degradation of viral NS3 through E3 ligase CUL2 (cullin 2)
Jiawei Hao, Jinqian Li, Zhenzhen Zhang, et al.
Autophagy (2022) Vol. 19, Iss. 4, pp. 1332-1347
Open Access | Times Cited: 20
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks
Lize Cuypers, Els Keyaerts, Samuel L. Hong, et al.
Nature Aging (2023) Vol. 3, Iss. 6, pp. 722-733
Open Access | Times Cited: 13
SARS-CoV-2 and the host-immune response
David P. Maison, Youping Deng, Mariana Gerschenson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA
Yusuke Kasuga, Ryota Ouda, Masashi Watanabe, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 24
Open Access | Times Cited: 12
Immunological mechanisms of the nucleocapsid protein in COVID-19
Fahime Edalat, Niloofar Khakpour, H. Heli, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 307-327
Closed Access | Times Cited: 4

Scroll to top